397 related articles for article (PubMed ID: 31253381)
21. Immunoglobulin heavy chain/light chain pairs (HLC, Hevylite™) assays for diagnosing and monitoring monoclonal gammopathies.
Kraj M
Adv Clin Exp Med; 2014; 23(1):127-33. PubMed ID: 24596015
[TBL] [Abstract][Full Text] [Related]
22. [The value of serum heavy/light chain immunoassay to assess therapeutic response in patients with multiple myeloma].
Yu XC; Su W; Zhuang JL
Zhonghua Xue Ye Xue Za Zhi; 2018 Apr; 39(4):281-285. PubMed ID: 29779321
[No Abstract] [Full Text] [Related]
23. Quantification of β region IgA paraproteins - should we include immunochemical "heavy/light chain" measurements? Counterpoint.
Paolini L
Clin Chem Lab Med; 2016 Jun; 54(6):1059-64. PubMed ID: 26812795
[TBL] [Abstract][Full Text] [Related]
24. Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma.
Suehara Y; Takamatsu H; Fukumoto K; Fujisawa M; Narita K; Usui Y; Takeuchi M; Endean K; Matsue K
Cancer Sci; 2017 Feb; 108(2):187-192. PubMed ID: 27889936
[TBL] [Abstract][Full Text] [Related]
25. [Effect of immunoglobulin heavy/light chain detection on the minimal residual disease monitoring in IgG multiple myeloma patients].
Zhang H; Zhou L; Li R; He J; Peng Z; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2015 Feb; 36(2):95-8. PubMed ID: 25778881
[TBL] [Abstract][Full Text] [Related]
26. IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia.
Boyle E; Manier S; Lejeune J; Fouquet G; Guidez S; Bonnet S; Debarri H; Demarquette H; Dulery R; Gay J; Hennache B; Onraed B; Faucompré JL; Schraen S; Facon T; Avet-Loiseau H; Chevret S; Leblond V; Harding S; Leleu X
Clin Cancer Res; 2016 Oct; 22(20):5152-5158. PubMed ID: 27169996
[TBL] [Abstract][Full Text] [Related]
27. Immunofluorescence staining for immunoglobulin heavy chain/light chain on kidney biopsies is a valuable ancillary technique for the diagnosis of monoclonal gammopathy-associated kidney diseases.
Nasr SH; Fidler ME; Said SM; Koepplin JW; Altamirano-Alonso JM; Leung N
Kidney Int; 2021 Jul; 100(1):155-170. PubMed ID: 33774084
[TBL] [Abstract][Full Text] [Related]
28. Quantification of β-region IgA monoclonal proteins - should we include immunochemical Hevylite® measurements? Point.
Evans JA; Jenner EL; Carr Smith HD; Berlanga O; Harding SJ
Clin Chem Lab Med; 2016 Jun; 54(6):1053-7. PubMed ID: 26485749
[TBL] [Abstract][Full Text] [Related]
29. Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio.
Prokaeva T; Spencer B; Sun F; O'Hara RM; Seldin DC; Connors LH; Sanchorawala V
Amyloid; 2016 Dec; 23(4):214-220. PubMed ID: 27677679
[TBL] [Abstract][Full Text] [Related]
30. Correlations among different markers determined by immunochemical methods used for the diagnosis and monitoring of intact immunoglobulin multiple myeloma cases.
Dogaru M; Lazăr V; Coriu D
Roum Arch Microbiol Immunol; 2012; 71(4):183-200. PubMed ID: 23755700
[TBL] [Abstract][Full Text] [Related]
31. Prognostic utility of intact immunoglobulin Ig'κ/Ig'λ ratios in multiple myeloma patients.
Bradwell A; Harding S; Fourrier N; Mathiot C; Attal M; Moreau P; Harousseau JL; Avet-Loiseau H
Leukemia; 2013 Jan; 27(1):202-7. PubMed ID: 22699454
[TBL] [Abstract][Full Text] [Related]
32. Within-subject biological variation of pairs of heavy/light immunoglobulin IgM chains (HLC IgM κ and λ) is low and requires monitoring: A comparison with HLC IgA, HLC IgG, and free light immunoglobulin chains (FLC) in healthy subjects.
Jabor A; Kubíček Z; Komrsková J; Sečník P; Vacková T; Vymětalík J; Franeková J
Clin Chim Acta; 2018 Nov; 486():311-312. PubMed ID: 30125534
[No Abstract] [Full Text] [Related]
33. Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteria.
Fouquet G; Snell KI; Guidez S; Schraen S; Boyle E; Renaud L; Desmier D; Machet A; Moya N; Systchenko T; Gruchet C; Decaux O; Arnulf B; Fohrer C; Richez V; Kolb B; Macro M; Karlin L; Royer B; Pegourie B; Hebraud B; Caillot D; Perrot A; Moreau P; Facon T; Avet-Loiseau H; Dejoie T; Hulin C; Harding S; Leleu X
Leuk Lymphoma; 2018 Mar; 59(3):583-589. PubMed ID: 28697637
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of Relationship between Serum Total Light Chain κ/λ Ratio and Proportion of Bone Marrow Plasma Cells in Patients with IgG type and IgA type Multiple Myeloma].
Zhu AY; Zhu FB; Wang FC; Zhang LJ; Ma Y; Hu JG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1454-1459. PubMed ID: 29070124
[TBL] [Abstract][Full Text] [Related]
35. Biological variation of immunoglobulin heavy chain-light chain pairs in serum.
Finlay JA; Wu AH
Clin Chim Acta; 2014 Sep; 436():68-71. PubMed ID: 24824555
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Hevylite™ IgA and IgG assay with conventional techniques for the diagnosis and follow-up of plasma cell dyscrasia.
Paolini L; Di Noto G; Maffina F; Martellosio G; Radeghieri A; Luigi C; Ricotta D
Ann Clin Biochem; 2015 May; 52(Pt 3):337-45. PubMed ID: 25468997
[TBL] [Abstract][Full Text] [Related]
37. [Diagnostic performance of κ/λ serum free light chain ratio (Freelite® assay) and IgGκ/IgGλ ratio (Hevylite® assay) as prognostic biomarkers of the evolution of immune thrombocytopenia into a chronic disease in adult patients].
Martellosio JP; Barra A; Roy-Peaud F; Souchaud-Debouverie O; Martin M; Lateur C; Gombert JM; Roblot P; Puyade M
Rev Med Interne; 2020 Jan; 41(1):3-7. PubMed ID: 31722837
[TBL] [Abstract][Full Text] [Related]
38. Heavy/light chain assay for monitoring IgA multiple myeloma: digging out the IgA from the β region.
Calderon B
Clin Chem; 2015 Feb; 61(2):317-8. PubMed ID: 25501934
[No Abstract] [Full Text] [Related]
39. Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease.
Isola I; Moreno DF; Moga E; Mena MP; Tovar N; Rodríguez-Lobato LG; Oliver-Caldés A; Salgado MC; Brasó-Maristany F; Yagüe J; Cibeira MT; Prat A; Rosiñol L; Bladé J; Fernández de Larrea C
Ann Hematol; 2021 Dec; 100(12):2997-3005. PubMed ID: 34463804
[TBL] [Abstract][Full Text] [Related]
40. Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports.
Gagliardi A; Carbone C; Russo A; Cuccurullo R; Lucania A; Cioppa PD; Misso G; Caraglia M; Tommasino C; Mastrullo L
Oncol Lett; 2016 Oct; 12(4):2363-2370. PubMed ID: 27698801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
